Zurn Elkay (ZWS) Reports Q1 2026 Earnings with Strong Financial Performance
Zurn Elkay (ZWS) reported Q1 2026 earnings with organic sales growth of 11%, driven by nonresidential markets, and total sales of $433 million. Adjusted EBITDA rose 18% to $116 million, with a margin expansion to 26.8%, and the company guided for 8%-9% core sales growth in Q2.
Topics: earnings EBITDA free cash flow guidance sales growth share repurchases